Lyfegen raised €5.4M in a Series A round in Dec 2024. The company is based in Basel, Switzerland. Investors in the round: aMoon, TX Ventures. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
